🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in France / NCT06589297
Recruiting Not applicable

Body Composition and Acute Stroke

NCT06589297 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2024-10-10
Last updated
2026-02-02

Condition(s) studied

Acute Stroke

Investigational drug(s) / intervention(s)

Modified Rankin scale

Modified Rankin scale: Acute stroke patients will undergo modified rankin scale

Study summary

Body composition appears to be a prognostic factor for the severity and functional outcome of stroke patients. In this study the prognostic value of two bioimpedance parameters will be studied (skeletal mass index and phase angle) and two temporal muscle measurements (thickness and surface area) to predict the functional outcome of patients at discharge and at 6 months

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * volunteer stroke patients in acute phase * Age ≥ 18 years * Having had a brain MRI * Able to understand assessment guidelines * Not having objected to participate in the study after being duly informed Exclusion Criteria: * Person under tutorship or curatorship * Person under court protection * Persons deprived of their liberty * Pregnant or breastfeeding women * Have a pacemaker or defibrillator

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CHU d'ORLEANS Orléans France Recruiting

More Centre Hospitalier Régional d'Orléans trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06589297 on ClinicalTrials.gov ↗ ← All trials in France